These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 20083590)
1. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Hanrahan CJ; Christensen CR; Crim JR Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590 [TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
6. PET and PET/CT in pediatric oncology. Jadvar H; Connolly LP; Fahey FH; Shulkin BL Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239 [TBL] [Abstract][Full Text] [Related]
7. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Metser U; Even-Sapir E Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma. Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787 [TBL] [Abstract][Full Text] [Related]
9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [TBL] [Abstract][Full Text] [Related]
10. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging. Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance. Adam Z; Bolcak K; Stanicek J; Buchler T; Pour L; Krejci M; Prasek J; Neubauer J; Vorlicek J; Hajek R Neoplasma; 2007; 54(6):536-40. PubMed ID: 17949238 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939 [TBL] [Abstract][Full Text] [Related]
15. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT flip flop phenomenon in treated lymphoma of bone. Lin EC Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078 [TBL] [Abstract][Full Text] [Related]
17. PET/CT in malignant bone disease. Even-Sapir E Semin Musculoskelet Radiol; 2007 Dec; 11(4):312-21. PubMed ID: 18324596 [TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056 [TBL] [Abstract][Full Text] [Related]
19. PET monitoring of therapy response in head and neck squamous cell carcinoma. Schöder H; Fury M; Lee N; Kraus D J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]